| Code | 6583D | ||||||||||
| MA number | 50/0032/21-S | ||||||||||
| Product Form: | tbl 90x40 mg (blis.PVC/PVDC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Medreg s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 50 - DIURETICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 19.02.2021 |
| Validity: | 19.02.2026 |
| MA renewed: | Renewal application submitted |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| Dokument: |
VHS_Furosemid Medreg_SK_H_0238_001_DC_PAR.doc
|
| Dokument: |
VHS_sum_Furosemid Medreg_SK_H_0238_001_DC_summary PAR.doc
|
| SPC: |
SPC_Furosemid Medreg_tbl_05_2024.pdf
|
| PIL: |
PIL_Furosemid Medreg_tbl_05_2024.pdf
|
| Safety feature | Yes |
| Data update: | 23.02.2021 |
